NGL FINECHEM
Back to Balance Sheet
|
NGL FINECHEM Last 5 Year Contingent Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Contingent Liabilities | ₹0.44 Cr | ₹0.10 Cr | ₹0.28 Cr | ₹0.28 Cr | ₹0.30 Cr |
What is the latest Contingent Liabilities ratio of NGL FINECHEM ?
Year | Contingent Liabilities |
---|---|
Mar2024 | ₹0.44 Cr |
Mar2023 | ₹0.10 Cr |
Mar2022 | ₹0.28 Cr |
Mar2021 | ₹0.28 Cr |
Mar2020 | ₹0.30 Cr |
How is Contingent Liabilities of NGL FINECHEM Trending?
Years | Contingent Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹0.44 Cr | 336.63 | |
Mar2023 | ₹0.10 Cr | -63.67 | |
Mar2022 | ₹0.28 Cr | 0.00 | |
Mar2021 | ₹0.28 Cr | -6.40 | |
Mar2020 | ₹0.30 Cr | - |
Compare Contingent Liabilities of peers of NGL FINECHEM
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
NGL FINECHEM | ₹763.8 Cr | 12.5% | 17% | -47% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹402,284.0 Cr | -0% | -0.4% | 10.2% | Stock Analytics | |
DIVIS LABORATORIES | ₹183,268.0 Cr | 1.4% | 4.1% | 50.3% | Stock Analytics | |
CIPLA | ₹122,253.0 Cr | 0.5% | 1.6% | 1.4% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹113,988.0 Cr | -1.2% | 7.1% | 18.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹108,921.0 Cr | 1.7% | 1.2% | 1.5% | Stock Analytics |
NGL FINECHEM Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
NGL FINECHEM | 12.5% |
17% |
-47% |
SENSEX | -0.7% |
3% |
5% |
You may also like the below Video Courses